levofloxacin has been researched along with Osteoarthritis in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fischer, M; Frontzek, A; Rieber, H | 1 |
| Chaves, F; Lora-Tamayo, J; Meléndez-Carmona, MÁ; Muñoz-Gallego, I; Viedma, E | 1 |
| Asseray, N; Bemer, P; Bourigault, C; Boutoille, D; Corvec, S; Happi, L; Navas, D; Touchais, S | 1 |
| Ariza, J; Baraia-Etxaburu, JM; Benito, N; Cobo, J; Del Toro, MD; Euba, G; Falgueras, L; Fernández-Sampedro, M; Horcajada, JP; Iribarren, JA; Jover-Sáenz, A; Lora-Tamayo, J; Palomino, J; Pigrau, C; Ramos, A; Riera, M; Sánchez-Somolinos, M; Sandoval, E; Soriano, A | 1 |
| Sauer, J; Seifert, A; Weyer, T | 1 |
1 review(s) available for levofloxacin and Osteoarthritis
| Article | Year |
|---|---|
Periprosthetic joint infection associated with Mycoplasma hominis after transurethral instrumentation in an immunocompetent patient. Unusual or underestimated? A case report and review of the literature.
Topics: Aged; Anti-Bacterial Agents; Doxycycline; Fatal Outcome; Humans; Joint Prosthesis; Joints; Levofloxacin; Male; Mycoplasma hominis; Mycoplasma Infections; Osteoarthritis; Prostatic Hyperplasia; Prosthesis-Related Infections | 2019 |
1 trial(s) available for levofloxacin and Osteoarthritis
| Article | Year |
|---|---|
Short- versus long-duration levofloxacin plus rifampicin for acute staphylococcal prosthetic joint infection managed with implant retention: a randomised clinical trial.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Debridement; Female; Humans; Levofloxacin; Male; Middle Aged; Osteoarthritis; Prosthesis Retention; Prosthesis-Related Infections; Rifampin; Time Factors; Treatment Outcome | 2016 |
3 other study(ies) available for levofloxacin and Osteoarthritis
| Article | Year |
|---|---|
Intraosteoblastic activity of levofloxacin and rifampin alone and in combination against clinical isolates of meticillin-susceptible Staphylococcus aureus causing prosthetic joint infection.
Topics: Anti-Bacterial Agents; Cell Line; Colony Count, Microbial; Humans; Levofloxacin; Microbial Sensitivity Tests; Microbial Viability; Models, Theoretical; Osteoarthritis; Osteoblasts; Prosthesis-Related Infections; Rifampin; Staphylococcal Infections; Staphylococcus aureus | 2019 |
Levofloxacin at the usual dosage to treat bone and joint infections: a cohort analysis.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Debridement; Female; France; Hospitals, Teaching; Humans; Levofloxacin; Male; Middle Aged; Osteoarthritis; Prosthesis-Related Infections; Retrospective Studies; Treatment Outcome | 2016 |
[Mitigated erysipelas after implantation of foreign material].
Topics: Aged; Anti-Infective Agents; Arthroplasty, Replacement; Arthroplasty, Replacement, Hip; Disease Progression; Erysipelas; Female; Follow-Up Studies; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Osteoarthritis; Osteoarthritis, Hip; Postoperative Complications; Prostheses and Implants; Prosthesis Implantation; Prosthesis-Related Infections; Reoperation; Shoulder Joint; Topoisomerase II Inhibitors | 2004 |